Cardiff Oncology, Inc. (CRDF) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-22

Cardiff Oncology, Inc. (CRDF) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 6 Form 8-K material event filings were reported by CRDF in the last 90 days. InsiderAlpha tracks every CRDF SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Cardiff Oncology, Inc. (CRDF)

SEC CIK	0001213037

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	6
Latest Form 4 filing	2026-06-22

Recent CRDF Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-18	PACE GARY W	Insider	P — Open-market purchase	30.0K	$1.22	$37K	SEC
2026-06-18	Mohindru Mani	Chief Executive Officer	P — Open-market purchase	24.7K	$1.21	$30K	SEC
2025-07-30	PACE GARY W	Insider	P — Open-market purchase	275.0K	$2.45	$674K	SEC
2025-07-30	PACE GARY W	Insider	P — Open-market purchase	15.0K	$2.45	$37K	SEC
2024-12-18	Levine James E.	Chief Financial Officer	P — Open-market purchase	2.4K	$5.00	$12K	SEC
2024-12-17	Levine James E.	Chief Financial Officer	P — Open-market purchase	2.8K	$5.42	$15K	SEC
2024-12-16	Levine James E.	Chief Financial Officer	P — Open-market purchase	2.6K	$3.83	$10K	SEC
2024-12-12	TANNENBAUM RENEE P	Insider	P — Open-market purchase	10.0K	$3.42	$34K	SEC
2024-12-11	PACE GARY W	Insider	P — Open-market purchase	11.5K	$2.60	$30K	SEC
2024-12-11	PACE GARY W	Insider	P — Open-market purchase	350.1K	$2.60	$910K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Cardiff Oncology, Inc. (CRDF). Updated in real time as new filings are submitted to the SEC.

Most-Active CRDF Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
PACE GARY W	2	$37K
TANNENBAUM RENEE P	1	—
White Lale	1	—
Armitage James O	1	—
Markin Rodney S	1	—

Recent CRDF Form 8-K Material Events

2026-07-16 — Item 1.01, 8.01, 9.01 [SEC]
2026-06-11 — Item 5.07 [SEC]
2026-06-03 — Item 7.01 [SEC]
2026-05-29 — Item 1.01 [SEC]
2026-05-19 — Item 8.01 [SEC]

Recent Insider Filings

2026-06-22 — Mohindru Mani (Chief Executive Officer)
2026-06-22 — PACE GARY W (Insider)
2026-06-16 — Armitage James O (Insider)
2026-06-16 — White Lale (Insider)
2026-06-16 — TANNENBAUM RENEE P (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CRDF insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CRDF Insider Trading — FAQ

What is the latest insider trade for CRDF?: Cardiff Oncology, Inc. (CRDF) had 8 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CRDF stock?: 0 insider purchases of CRDF were filed in the last 90 days.
How many insiders are selling CRDF stock?: 0 insider sales of CRDF were filed in the last 90 days.
Where can I see CRDF SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CRDF SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CRDF dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.